Moors & Cabot, Inc. Charles River Laboratories International, Inc. Transaction History

Moors & Cabot, Inc.

$2.05 Billion
Q2 2025

A detailed history of Moors & Cabot, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Moors & Cabot, Inc. holds 1,685 shares of CRL stock, worth $294,790. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,685

Previous 1,811 6.96%

Holding current value

$294,790

Previous $272,000 6.25%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	SELL	$99.75 - $151.89 $12,568 - $19,138	-126 Reduced 6.96%	1,685 $255,000
Q1 2025 May 08, 2025	SELL	$150.52 - $190.14 $451 - $570	-3 Reduced 0.17%	1,811 $272,000
Q4 2024 Feb 07, 2025	BUY	$178.58 - $220.69 $1,607 - $1,986	9 Added 0.5%	1,814 $334,000
Q3 2024 Nov 08, 2024	SELL	$187.96 - $245.29 $35,712 - $46,605	-190 Reduced 9.52%	1,805 $355,000
Q2 2024 Aug 09, 2024	BUY	$206.39 - $268.73 $3,715 - $4,837	18 Added 0.91%	1,995 $412,000
Q1 2024 May 08, 2024	SELL	$203.52 - $273.43 $60,852 - $81,755	-299 Reduced 13.14%	1,977 $535,000
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $822 - $1,194	-5 Reduced 0.22%	2,276 $538,000
Q3 2023 Nov 07, 2023	SELL	$194.44 - $217.61 $14,388 - $16,103	-74 Reduced 3.14%	2,281 $447,000
Q2 2023 Aug 09, 2023	BUY	$183.71 - $210.25 $19,840 - $22,707	108 Added 4.81%	2,355 $495,000
Q1 2023 May 04, 2023	BUY	$191.89 - $259.92 $3,454 - $4,678	18 Added 0.81%	2,247 $453,000
Q4 2022 Feb 09, 2023	BUY	$197.11 - $250.07 $84,954 - $107,780	431 Added 23.97%	2,229 $485,000
Q4 2022 Feb 06, 2023	SELL	$197.11 - $250.07 $67,214 - $85,273	-341 Reduced 15.94%	1,798 $391,000
Q3 2022 Nov 07, 2022	BUY	$182.44 - $250.54 $27,548 - $37,831	151 Added 7.6%	2,139 $421,000
Q2 2022 Aug 08, 2022	BUY	$204.13 - $302.4 $20,413 - $30,239	100 Added 5.3%	1,988 $425,000
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $2,555 - $3,621	-10 Reduced 0.53%	1,888 $536,000
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $35,138 - $44,868	100 Added 5.56%	1,898 $715,000
Q3 2021 Dec 08, 2021	SELL	$372.64 - $458.3 $9.61 Million - $11.8 Million	-25,798 Reduced 93.48%	1,798 $743,000
Q3 2021 Nov 05, 2021	BUY	$372.64 - $458.3 $10.3 Million - $12.6 Million	27,596 New	27,596 $610,000

Others Institutions Holding CRL

# of Institutions

617

Shares Held

53.2M

Call Options Held

1.42M

Put Options Held

1.42M

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.9B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account